KAPA Kairos Pharma Inc Company Cash on Hand

Kairos Pharma Ltd (KAPA) relies on long-term patents and partner support, which guarantees capital inflows. The volume of physical cash confirms this resilience, with the metric level standing at 0.00. However, the fierce struggle for FDA certification creates risks. To minimize supplier dependency, management is distributing the testing of new molecules across different laboratories.
Analytical breakdowns for Kairos Pharma Ltd
- stock value and consensus price forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
Total Debt to Capital Kairos Pharma Ltd|KAPA - Long-Term Debt to Capital|Short-Term Debt to Equity Kairos Pharma Limited|KAPA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Kairos Pharma|KAPA - Company Long-Term Liabilities|Company Short-Term Debts Kairos Pharma|Quick Liquidity Indicator kairospharma.com
- company profitability and valuation multiples indicators:
KAPA - Final Profit|Expected Profit Kairos Pharma Ltd|KAPA - Price to Earnings Ratio|Projected Price to Earnings Kairos Pharma Ltd|KAPA - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Kairos Pharma Ltd|KAPA - Operating profit before amortization|Earnings per share for the last twelve months Kairos Pharma|KAPA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth kairospharma.com|KAPA - Earnings growth in current year|Net earnings per share growth forecast for next year Kairos Pharma Ltd
- sales and revenue indicators:
- margin level details:
- cash balance and cash flow data:
Fundamental valuation:KAPA Kairos Pharma Ltd

Adhering to strict cold chain standards for the delivery of oncology drugs requires significant operational logistics expenditures from Kairos Pharma Ltd (KAPA). The current value of 0.00 reflects the volume of liquid reserves, allowing investors to assess the balance between financial stability and capital efficiency through the amount of cash holdings.
Competitors of Kairos Pharma Ltd
Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Company Total Cash Volume URGN|BCAX: Company Cash Volume|PSNL - Company Liquid Assets|ERAS (Erasca Inc) - Company Cash Volume|Company Cash Reserve Delcath Systems Inc DCTH|Company Cash Funds YmAbs (YMAB)|Company Liquid Assets Aura Bio|Company Cash Volume CADL (Candel Therapeutics Inc.)|accuray.com (ARAY) - Company Cash Reserve|SELLAS Life Sciences Group - Company Cash Volume|ACTU - Company Cash Volume|CTOR: Company Cash Volume|Company Cash Reserve TuHURA (HURA)|TARA (Protara Therapeutics Inc) - Company Cash Volume|Fate Therapeutics, Inc. (FATE) - Company Liquid Assets|Company Cash on Hand WHWK (Aadi Bioscience, Inc.)|Company Liquid Assets TScan Therapeutics, Inc.|Company Cash Volume CSBR (Champions Oncology Corp)|Company Total Cash Amount XBIT (XBiotech USA)|CVM - Company Cash Funds|Company Cash Balance OSTX (ostherapies.com)|Radiopharm Theranostics Ltd (RADX) - Company Cash Funds|ARTV: Company Total Cash Amount|ANL (adlainortye.com) - Company Cash Volume|VERU: Company Cash Balance|Company Cash on Hand TPST (Tempest Tx)|Company Cash on Hand Xilio XLO|Company Cash Volume RENB (Renovaro)|Company Cash Volume Mural Bio MURA|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds